Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 24, 15:59
36.90
1.35 (3.8%)
VOLUME 385,307
LIVE
NSE
Apr 24, 15:52
36.90
1.4 (3.94%)
VOLUME 1,638,878
Announcements on Orchid Pharma

20th-Apr-2017 18:36Source: BSE

Orchid Pharma- Statement Of Investor Complaints For The Quarter Ended March 31, 2017

Statement of Investor Complaints during the three months from January 01, 2017 to March 31, 2017, pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations...

19th-Apr-2017 18:00Source: BSE

Orchid Pharma- Shareholding for the Period Ended March 31, 2017

Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly

18th-Apr-2017 13:13Source: BSE

Orchid Pharma- Press Release

Establishment Inspection Report from USFDA

18th-Apr-2017 12:54Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange regarding a press release dated April 18, 2017, titled "Establishment Inspection Report from USFDA".

17th-Apr-2017 17:37Source: BSE

Orchid Pharma- Credit Rating

Intimation of Revision in ratings under SEBI(Listing obligations and Disclosure Requirements), Regulations, 2015

6th-Apr-2017 11:06Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for

23rd-Mar-2017 10:41Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for R Vijayalakshmi

16th-Mar-2017 10:50Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for R Vijayalakshmi

9th-Mar-2017 13:10Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for R Vijayalakshmi

23rd-Feb-2017 14:14Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange regarding Intimation of Change in Name of Registry activity of our Registrar and Share Transfer Agent.

1 2 3 4 5 Next >>
Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.